Ono Pharmaceutical
(OTC) OPHLY
Ono Pharmaceutical Financials at a Glance
Market Cap
$7.46B
Revenue (TTM)
$514.13B
Net Income (TTM)
$63.40B
EPS (TTM)
$0.30
P/E Ratio
17.81
Dividend
$0.18
Beta (Volatility)
0.23 (Low)
Dividend
$0.18
Beta (Volatility)
0.23 (Low)
Price
$5.29
Volume
10,545
Open
$5.25
Price
$5.29
Volume
10,545
Open
$5.25
Previous Close
$5.29
Daily Range
$5.25 - $5.31
52-Week Range
$3.28 - $5.75
Dividend
$0.18
Beta (Volatility)
0.23 (Low)
Price
$5.29
Volume
10,545
Open
$5.25
Previous Close
$5.29
Daily Range
$5.25 - $5.31
52-Week Range
$3.28 - $5.75
OPHLY News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Ono Pharmaceutical
Industry
Pharmaceuticals
Sector
Health CareEmployees
4,287
CEO
Gyo Sagara
Website
www.ono-pharma.com/jaHeadquarters
Osaka, 541-8564, JP
OPHLY Financials
Key Financial Metrics (TTM)
Gross Margin
70%
Operating Margin
16%
Net Income Margin
12%
Return on Equity
8%
Return on Capital
9%
Return on Assets
6%
Earnings Yield
5.61%
Dividend Yield
0.03%
Payout Ratio
59.97%
Stock Overview
Market Cap
$7.46B
Shares Outstanding
1.41B
Volume
10.54K
Short Interest
0.00%
Avg. Volume
25.53K
Financials (TTM)
Gross Profit
$338.92B
Operating Income
$59.75B
EBITDA
$91.54B
Operating Cash Flow
$82.46B
Capital Expenditure
$7.99B
Free Cash Flow
$74.47B
Cash & ST Invst.
$210.38B
Total Debt
$146.68B
Ono Pharmaceutical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$142.43B
+6.1%
Gross Profit
$105.08B
+18.9%
Gross Margin
73.78%
N/A
Market Cap
$7.46B
N/A
Market Cap/Employee
$1.94M
N/A
Employees
3,853
N/A
Net Income
$29.38B
+96.5%
EBITDA
$48.06B
+99.9%
Quarterly Fundamentals
Net Cash
$57.31B
+246.2%
Accounts Receivable
$149.59B
-1.7%
Inventory
$66.14B
-14.8%
Long Term Debt
$97.71B
-19.4%
Short Term Debt
$34.38B
+4.2%
Return on Assets
5.75%
N/A
Return on Invested Capital
8.85%
N/A
Free Cash Flow
$32.02B
+58459.9%
Operating Cash Flow
$33.04B
+52311.7%